Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy

NCT00307164 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

167

Enrollment

NIH

Sponsor class

Conditions

HIV Infections
Lipoatrophy

Interventions

DRUG: NucleomaxX
DRUG: NucleomaxX placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)